本文已被:浏览 826次 下载 979次 |
![本文二维码信息](/uploadfile/two_dimensional_code_img/zhonggsyzz/2022/11/20220507002.png) 码上扫一扫! |
牛病毒性腹泻/黏膜病(1型+2型)、牛传染性鼻气管炎、牛副流感(3型)三联灭活疫苗(E2蛋白+C1株+HB01株)的研制与免疫效果评价 |
赵卓,胡义彬,雷莉辉,武沛泽,武春霞,马岩,张巨峰,王力,江厚生 |
|
(1.北京生泰尔科技股份有限公司 2. 北京华夏兴洋生物科技有限公司) |
|
摘要: |
采用CHO细胞表达牛病毒性腹泻/黏膜病病毒1型(BVDV1)E2蛋白,采用杆状病毒重组表达牛病毒性腹泻/黏膜病病毒2型(BVDV2)E2蛋白,采用MDBK细胞微载体悬浮培养技术培养牛传染性鼻气管炎病毒(IBRV)和牛副流感病毒3型(BPIV3),收获蛋白表达产物和细胞培养物,经纯化、灭活后与605佐剂混合,制备牛病毒性腹泻/黏膜病(1型+2型)、牛传染性鼻气管炎、牛副流感(3型)三联灭活疫苗(E2蛋白+C1株+HB01株)。将疫苗免疫健康易感牛进行免疫效果评价,结果表明该产品免疫效果良好,免疫牛IBRV和BPIV3中和抗体效价均可达到1∶77以上;BVDV1和BVDV2 E2蛋白琼扩抗体效价均可达到1∶32以上;免疫牛攻毒保护率均可达到4/5以上。 |
关键词: 牛病毒性腹泻/黏膜病 牛传染性鼻气管炎 牛副流感 灭活疫苗 免疫效力 |
DOI: |
投稿时间:2022-05-07修订日期:2022-11-01 |
基金项目:内蒙古自治区科技重大专项-牛腹泻疾病防控关键技术研发与标准化操作规程示范推广(2020ZD0006) |
|
Development and Immune Effect Evaluation of Bovine Viral Diarrhea/Mucosal Disease (Type 1+Type 2), Infectious Bovine Rhinotracheitis and Bovine Parainfluenza (Type 3) Inactivated Vaccines (E2 Protein+C1 Strain+HB01 Strain) |
|
(1. Beijing Centre Biology Co.,Ltd. 2. Beijing Centrebio Biology Co., Ltd) |
Abstract: |
In this study, CHO cells were used to express bovine viral diarrhea/mucosal disease virus type 1 (BVDV1)E2 protein, baculovirus recombinant was used to express bovine viral diarrhea/mucosal disease virus type 2(BVDV2) E2 protein, and MDBK cell microcarrier suspension culture technology was used to culture bovine infectious rhinotracheitis virus (IBRV) and bovine parainfluenza virus type 3 (BPIV3). The protein expression products and virus cultures were harvested and mixed with 605 adjuvant after purification and inactivation to prepare inactivated vaccine of bovine viral diarrhea/mucosal disease (type 1+type 2), infectious bovine rhinotracheitis and bovine parainfluenza (type 3) (E2 protein + C1 strain+HB01 strain). The results showed that the immune effect was good, and the titers of IBRV and BPIV3 neutralizing antibodies of immunized cattle were more than 1∶77; The titers of BVDV1 and BVDV2 E2 protein antibody could reach more than 1∶32; The protection rate of immunized cattle against virus could reach more than 4/5. |
Key words: bovine viral diarrhea/mucosal disease infectious bovine rhinotracheitis bovine parainfluenza inactivated vaccine immune efficacy |